Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice

Genes, Brain and Behavior

Volumn 10, Issue 7, 2011, Pages 720-733

  Young, J W ^a   Meves, J M ^a   Tarantino, I S ^a   Caldwell, S ^a   Geyer, M A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

7 nicotinic acetylcholine receptor; Exploration; Mice; Motivation; Mutant; Prepulse inhibition; Procedural learning; Schizophrenia; Set shifting; Short term memory

Indexed keywords

BUNGAROTOXIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; COGNITION; CONTROLLED STUDY; DISCRIMINATION LEARNING; EXECUTIVE FUNCTION; EXPLORATORY BEHAVIOR; FEMALE; FOOD; HABITUATION; KNOCKOUT MOUSE; LEARNING; MALE; MOTIVATION; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RECOGNITION; REWARD; SENSORY GATING; SHORT TERM MEMORY; SPATIAL MEMORY; TASK PERFORMANCE; WILD TYPE; WORKING MEMORY;

ANIMALS; ATTENTION; COGNITION; EXECUTIVE FUNCTION; EXPLORATORY BEHAVIOR; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTIVATION; PATTERN RECOGNITION, PHYSIOLOGICAL; RECEPTORS, NICOTINIC; RECOGNITION (PSYCHOLOGY); SENSORY GATING;

MUS;

EID: 80053654164     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2011.00711.x     Document Type: Article

References (90)

1. Adcock, R.A., Dale, C., Fisher, M., Aldebot, S., Genevsky, A., Simpson, G.V., Nagarajan, S. & Vinogradov, S. (2009) When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophr Bull 35, 1132-1141.
2. Ali, S.S., Young, J.W., Wallace, C.K., Gresack, J., Jeste, D.V., Geyer, M.A., Dugan, L.L. & Risbrough, V.B. (2011) Initial evidence linking synaptic superoxide production with poor short-term memory in aged mice. Brain Res 1368, 65-70.
3. Barr, A.M., Powell, S.B., Markou, A. & Geyer, M.A. (2006) Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats. Neuropharmacology 51, 457-465.
4. Barr, R.S., Culhane, M.A., Jubelt, L.E., Mufti, R.S., Dyer, M.A., Weiss, A.P., Deckersbach, T., Kelly, J.F., Freudenreich, O., Goff, D.C. & Evins, A.E. (2008) The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology 33, 480-490.
5. Bensadoun, J.C., Brooks, S.P. & Dunnett, S.B. (2004) Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine. Psychopharmacology (Berl) 174, 396-405.
6. Birrell, J.M. & Brown, V.J. (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20, 4320-4324.
7. Bissonette, G.B., Martins, G.J., Franz, T.M., Harper, E.S., Schoenbaum, G. & Powell, E.M. (2008) Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J Neurosci 28, 11124-11130.
8. Buchanan, R.W., Davis, M., Goff, D., Green, M.F., Keefe, R.S., Leon, A.C., Nuechterlein, K.H., Laughren, T., Levin, R., Stover, E., Fenton, W. & Marder, S.R. (2005) A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 31, 5-19.
9. Castane, A., Theobald, D.E. & Robbins, T.W. (2010) Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats. Behav Brain Res 210, 74-83.
10. Cilia, J., Cluderay, J.E., Robbins, M.J., Reavill, C., Southam, E., Kew, J.N. & Jones, D.N. (2005) Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist. Psychopharmacology (Berl) 182, 214-219.
11. Csomor, P.A., Yee, B.K., Vollenweider, F.X., Feldon, J., Nicolet, T. & Quednow, B.B. (2008) On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behav Neurosci 122, 885-900.
12. D'Souza, M.S. & Markou, A. (2011) Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology. (in press).
13. De Luca, V., Likhodi, O., Van Tol, H.H., Kennedy, J.L. & Wong, A.H. (2006) Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia. Acta Psychiatr Scand 114, 211-215.
14. DeVito, L.M., Kanter, B.R. & Eichenbaum, H. (2010a) The hippocampus contributes to memory expression during transitive inference in mice. Hippocampus 20, 208-217.
15. DeVito, L.M., Lykken, C., Kanter, B.R. & Eichenbaum, H. (2010b) Prefrontal cortex: role in acquisition of overlapping associations and transitive inference. Learn Mem 17, 161-167.
16. Dickson, P.E., Rogers, T.D., Del Mar, N., Martin, L.A., Heck, D., Blaha, C.D., Goldowitz, D. & Mittleman, G. (2010) Behavioral flexibility in a mouse model of developmental cerebellar Purkinje cell loss. Neurobiol Learn Mem 94, 220-228.
17. Eack, S.M., Hogarty, G.E., Cho, R.Y., Prasad, K.M., Greenwald, D.P., Hogarty, S.S. & Keshavan, M.S. (2010) Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 67, 674-682.
18. Eichenbaum, H. & Fortin, N.J. (2009) The neurobiology of memory based predictions. Philos Trans R Soc Lond B Biol Sci 364, 1183-1191.
19. Feldman, J. (2004) How surprising is a simple pattern? Quantifying "Eureka!". Cognition 93, 199-224.
20. Freedman, R., Coon, H., Myles-Worsley, M. et al (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 94, 587-592.
21. Freedman, R., Olincy, A., Buchanan, R.W., Harris, J.G., Gold, J.M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M.P., Kutnick, J., Pender, V., Martin, L.F., Stevens, K.E., Wagner, B.D., Zerbe, G.O., Soti, F. & Kem, W.R. (2008) Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry 165, 1040-1047.
22. Genevsky, A., Garrett, C.T., Alexander, P.P. & Vinogradov, S. (2010) Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues Clin Neurosci 12, 416-421.
23. Geyer, M.A. & Tamminga, C.A. (2004) Measurement and treatment research to improve cognition in schizophrenia: Neuropharmacological aspects. Psychopharmacology 174, 1-2.
24. Geyer, M.A., Russo, P.V. & Masten, V.L. (1986) Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol Biochem Behav 25, 277-288.
25. Giovannelli, F., Silingardi, D., Borgheresi, A., Feurra, M., Amati, G., Pizzorusso, T., Viggiano, M.P., Zaccara, G., Berardi, N. & Cincotta, M. (2010) Involvement of the parietal cortex in perceptual learning (Eureka effect): an interference approach using rTMS. Neuropsychologia 48, 1807-1812.
26. Gruzelier, J., Seymour, K., Wilson, L., Jolley, A. & Hirsch, S. (1988) Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders. Arch Gen Psychiatry 45, 623-629.
27. Halberstadt, A.L., van der Heijden, I., Ruderman, M.A., Risbrough, V.B., Gingrich, J.A., Geyer, M.A. & Powell, S.B. (2009) 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology 34, 1958-1967.
28. Haut, K.M., Lim, K.O. & MacDonald, A. III (2010) Prefrontal cortical changes following cognitive training in patients with chronic schizophrenia: effects of practice, generalization, and specificity. Neuropsychopharmacology 35, 1850-1859.
29. Henry, B.L., Minassian, A., Young, J.W., Paulus, M.P., Geyer, M.A. & Perry, W. (2010) Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neurosci Biobehav Rev 34, 1296-1306.
30. Hoyle, E., Genn, R.F., Fernandes, C. & Stolerman, I.P. (2006) Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology (Berl) 189, 211-223.
31. Izquierdo, A., Belcher, A.M., Scott, L., Cazares, V.A., Chen, J., O'Dell, S.J., Malvaez, M., Wu, T. & Marshall, J.F. (2010) Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine. Neuropsychopharmacology 35, 505-514.
32. Keller, J.J., Keller, A.B., Bowers, B.J. & Wehner, J.M. (2005) Performance of alpha7 nicotinic receptor null mutants is impaired in appetitive learning measured in a signaled nose poke task. Behav Brain Res 162, 143-152.
33. Komada, M., Takao, K. & Miyakawa, T. (2008) Elevated plus maze for mice. J Vis Exp. DOI: 10.3791/1088.
34. Kumari, V. & Postma, P. (2005) Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 29, 1021-1034.
35. Leary, R.W. (1962)"Spontaneous reversal" in the serial-discrimination reversal learning of monkeys. Can J Psychol 16, 228-233.
36. Levin, E.D., Conners, C.K., Silva, D., Hinton, S.C., Meck, W.H., March, J. & Rose, J.E. (1998) Transdermal nicotine effects on attention. Psychopharmacology (Berl) 140, 135-141.
37. Levin, E.D., McClernon, F.J. & Rezvani, A.H. (2006) Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184, 523-539.
38. Levin, E.D., Petro, A., Rezvani, A.H., Pollard, N., Christopher, N.C., Strauss, M., Avery, J., Nicholson, J. & Rose, J.E. (2009) Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. Behav Brain Res 196, 207-213.
39. Lockman, P.R., Van der Schyf, C.J., Abbruscato, T.J. & Allen, D.D. (2005) Chronic nicotine exposure alters blood-brain barrier permeability and diminishes brain uptake of methyllycaconitine. J Neurochem 94, 37-44.
40. Mansbach, R.S. & Geyer, M.A. (1988) Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands. Eur J Pharmacol 156, 375-383.
41. Marder, S.R. (2006) The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia. Dialogues Clin Neurosci 8, 109-113.
42. Marks, M.J., Whiteaker, P., Calcaterra, J., Stitzel, J.A., Bullock, A.E., Grady, S.R., Picciotto, M.R., Changeux, J.P. & Collins, A.C. (1999) Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. J Pharmacol Exp Ther 289, 1090-1103.
43. Martin, L.F., Kem, W.R. & Freedman, R. (2004) Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) 174, 54-64.
44. Martin-Ruiz, C.M., Haroutunian, V.H., Long, P., Young, A.H., Davis, K.L., Perry, E.K. & Court, J.A. (2003) Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia. Biol Psychiatry 54, 1222-1233.
45. McAlonan, K. & Brown, V.J. (2003) Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 146, 97-103.
46. Milner, B. (1971) Interhemispheric differences in the localization of psychological processes in man. Br Med Bull 27, 272-277.
47. Miwa, J.M., Freedman, R. & Lester, H.A. (2011) Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 70, 20-33.
48. Myers, C.S., Taylor, R.C., Moolchan, E.T. & Heishman, S.J. (2008) Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray. Neuropsychopharmacology 33, 588-598.
49. Newhouse, P., Singh, A. & Potter, A. (2004) Nicotine and nicotinic receptor involvement in neuropsychiatric disorders. Curr Top Med Chem 4, 267-282.
50. Nuechterlein, K.H., Barch, D.M., Gold, J.M., Goldberg, T.E., Green, M.F. & Heaton, R.K. (2004) Identification of separable cognitive factors in schizophrenia. Schizophr Res 72, 29-39.
51. Olincy, A., Harris, J.G., Johnson, L.L., Pender, V., Kongs, S., Allensworth, D., Ellis, J., Zerbe, G.O., Leonard, S., Stevens, K.E., Stevens, J.O., Martin, L., Adler, L.E., Soti, F., Kem, W.R. & Freedman, R. (2006) Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry, 63, 630-638.
52. Orr-Urtreger, A., Goldner, F.M., Saeki, M., Lorenzo, I., Goldberg, L., De Biasi, M., Dani, J.A., Patrick, J.W. & Beaudet, A.L. (1997) Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 17, 9165-9171.
53. Ouagazzal, A.M., Reiss, D. & Romand, R. (2006) Effects of age-related hearing loss on startle reflex and prepulse inhibition in mice on pure and mixed C57BL and 129 genetic background. Behav Brain Res 172, 307-315.
54. Paulus, M.P. & Geyer, M.A. (1991) A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology (Berl) 104, 6-16.
55. Paulus, M.P. & Geyer, M.A. (1993) Three independent factors characterize spontaneous rat motor activity. Behav Brain Res 53, 11-20.
56. Paylor, R., Nguyen, M., Crawley, J.N., Patrick, J., Beaudet, A. & Orr-Urtreger, A. (1998) Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem 5, 302-316.
57. Perkins, K.A., Epstein, L.H., Stiller, R.L., Fernstrom, M.H., Sexton, J.E., Jacob, R.G. & Solberg, R. (1991) Acute effects of nicotine on hunger and caloric intake in smokers and nonsmokers. Psychopharmacology (Berl) 103, 103-109.
58. Perry, W., Minassian, A., Paulus, M.P., Young, J.W., Kincaid, M.J., Ferguson, E.J., Henry, B.L., Zhuang, X., Masten, V.L., Sharp, R.F. & Geyer, M.A. (2009) A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry 66, 1072-1080.
59. Poltavski, D.V. & Petros, T. (2006) Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits. Physiol Behav 87, 614-624.
60. Poorthuis, R.B., Goriounova, N.A., Couey, J.J. & Mansvelder, H.D. (2009) Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences. Biochem Pharmacol 78, 668-676.
61. Premkumar, P., Parbhakar, V.A., Fannon, D., Lythgoe, D., Williams, S.C., Kuipers, E. & Kumari, V. (2010) N-acetyl aspartate concentration in the anterior cingulate cortex in patients with schizophrenia: a study of clinical and neuropsychological correlates and preliminary exploration of cognitive behaviour therapy effects. Psychiatry Res 182, 251-260.
62. Rathod, S., Phiri, P. & Kingdon, D. (2010) Cognitive behavioral therapy for schizophrenia. Psychiatr Clin North Am 33, 527-536.
63. Risbrough, V.B., Masten, V.L., Caldwell, S., Paulus, M.P., Low, M.J. & Geyer, M.A. (2006) Differential contributions of dopamine D(1), D(2), and D(3) receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology 31, 2349-2358.
64. Robbins, T.W. (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163, 362-380.
65. Rygula, R., Walker, S.C., Clarke, H.F., Robbins, T.W. & Roberts, A.C. (2010) Differential contributions of the primate ventrolateral prefrontal and orbitofrontal cortex to serial reversal learning. J Neurosci 30, 14552-14559.
66. Seu, E. & Jentsch, D.J. (2009) Effect of acute and repeated treatment with desipramine or methylphenidate on serial reversal learning in rats. Neuropharmacology 57, 665-672.
67. Swerdlow, N.R. (2010) Integrative circuit models and their implications for the pathophysiologies and treatments of the schizophrenias. In Swerdlow, N.R. (ed.), Behavioral Neurobiology of schizophrenia and its treatment. Springer-Verlag, Berlin.
68. Tait, D.S., Marston, H.M., Shahid, M. & Brown, V.J. (2009) Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions. Psychopharmacology (Berl) 202, 295-306.
69. Tamminga, C.A. (2006) The neurobiology of cognition in schizophrenia. J Clin Psychiatry 67 (Suppl. 9), 9-13; discussion 36-42.
70. Tarantino, I.S., Sharp, R.F., Geyer, M.A., Meves, J.M. & Young, J.W. (2011) Working memory span capacity improved by a D2 but not D1 receptor family agonist. Behav Brain Res 219, 181-188.
71. Tarrier, N. (2010) Cognitive behavior therapy for schizophrenia and psychosis: current status and future directions. Clin Schizophr Relat Psychoses 4, 176-184.
72. Thomsen, M.S., Christensen, D.Z., Hansen, H.H., Redrobe, J.P. & Mikkelsen, J.D. (2009) alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment. Neuropharmacology 56, 1001-1009.
73. Tsushima, Y. & Watanabe, T. (2009) Roles of attention in perceptual learning from perspectives of psychophysics and animal learning. Learn Behav 37, 126-132.
74. Turek, J.W., Kang, C.H., Campbell, J.E., Arneric, S.P. & Sullivan, J.P. (1995) A sensitive technique for the detection of the alpha 7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain. J Neurosci Methods 61, 113-118.
75. Twamley, E.W., Savla, G.N., Zurhellen, C.H., Heaton, R.K. & Jeste, D.V. (2008) Development and pilot testing of a novel compensatory cognitive training intervention for people with psychosis. Am J Psychiatr Rehabil 11, 144-163.
76. Vanderploeg, R.D., Schinka, J.A. & Retzlaff, P. (1994) Relationships between measures of auditory verbal learning and executive functioning. J Clin Exp Neuropsychol 16, 243-252.
77. Wenk, G.L. (2004) Assessment of spatial memory using the radial arm maze and Morris water maze. Curr Protoc Neurosci, Chapter 8, Unit 8.5A.
78. Whiteaker, P., Davies, A.R., Marks, M.J., Blagbrough, I.S., Potter, B.V., Wolstenholme, A.J., Collins, A.C. & Wonnacott, S. (1999) An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur J Neurosci 11, 2689-2696.
79. Wimber, M., Heinze, H.J. & Richardson-Klavehn, A. (2010) Distinct frontoparietal networks set the stage for later perceptual identification priming and episodic recognition memory. J Neurosci 30, 13272-13280.
80. Young, J.W. & Geyer, M.A. (2010) Action of modafinil-increased motivation via the dopamine transporter inhibition and D1 receptors? Biol Psychiatry 67, 784-787.
81. Young, J.W., Finlayson, K., Spratt, C., Marston, H.M., Crawford, N., Kelly, J.S. & Sharkey, J. (2004) Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology 29, 891-900.
82. Young, J.W., Crawford, N., Kelly, J.S., Kerr, L.E., Marston, H.M., Spratt, C., Finlayson, K. & Sharkey, J. (2007a) Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur Neuropsychopharmacol 17, 145-155.
83. Young, J.W., Kerr, L.E., Kelly, J.S., Marston, H.M., Spratt, C., Finlayson, K. & Sharkey, J. (2007b) The odour span task: a novel paradigm for assessing working memory in mice. Neuropharmacology 52, 634-645.
84. Young, J.W., Minassian, A., Paulus, M.P., Geyer, M.A. & Perry, W. (2007c) A reverse-translational approach to bipolar disorder: rodent and human studies in the behavioral pattern monitor. Neurosci Biobehav Rev 31, 882-896.
85. Young, J.W., Sharkey, J. & Finlayson, K. (2008) Progressive impairment in olfactory working memory in a mouse model of mild cognitive impairment. Neurobiol Aging 30, 1430-1443.
86. Young, J.W., Light, G.A., Marston, H.M., Sharp, R. & Geyer, M.A. (2009a) The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. PLoS ONE 4, e4227.
87. Young, J.W., Powell, S.B., Risbrough, V., Marston, H.M. & Geyer, M.A. (2009b) Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther 122, 150-202.
88. Young, J.W., Goey, A.K., Minassian, A., Perry, W., Paulus, M.P. & Geyer, M.A. (2010a) The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacol Biochem Behav 96, 7-15.
89. Young, J.W., Powell, S.B., Geyer, M.A., Jeste, D.V. & Risbrough, V.B. (2010b) The mouse attentional set-shifting task: a method for assaying successful cognitive aging? Cogn Affect Behav Neurosci 10, 243-251.
90. Young, J.W., Wallace, C.K., Geyer, M.A. & Risbrough, V.B. (2010c) Age-associated improvements in cross-modal prepulse inhibition in mice. Behav Neurosci 124, 133-140.